GEN Exclusives

More »

GEN News Highlights

More »
Dec 21, 2007

FDA Finds Satisfactory Resolution of Akorn cGMP Issues

  • Akorn reports positive results from a recent FDA cGMP compliance inspection of the Decatur, IL manufacturing facility. This inspection also served as a preapproval inspection (PAI) for Akorn’s new lyophilization operation.

    As a result of this inspection, Akorn is now eligible for pending product approvals in its ophthalmic, ampoule, liquid vial, and lyophilization production filling suites in Decatur.

    According to Akorn, the agency found satisfactory resolution of past cGMP issues. The FDA District of Chicago office also confirmed they had reported to the FDA Center for Drug Evaluation and Research that the firm’s responses to the subject inspection appear to be acceptable.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »